USP15 has been shown to stabilize TGF-β receptor I and promote oncogenesis through the activation of TGF-β signaling in glioblastoma [6], and the USP15 gene is also amplified myeloma and ovarian cancers [7, 8]. Here, USP15 is linked to plasma cell myeloma.